Thursday's pre-market session: top gainers and losers
By Mill Chart
Last update: May 2, 2024
Get insights into the top gainers and losers of Thursday's pre-market session.
Gainers
| Ticker | Change | Comment |
|---|---|---|
| ALLR | 131.0% | During Thursday's pre-market trading, ALLARITY THERAPEUTICS INC (NASDAQ:ALLR) demonstrated strong momentum, with the stock price rising 131.0% to $3.17. Earlier today the company had a press release: Allarity Therapeutics’ Stenoparib Shows Clear Clinical Benefit and Achieves Significant Milestone with Early Conclusion of Phase 2 Trial in Advanced Ovarian Cancer. |
| EBS | 57.51% | EMERGENT BIOSOLUTIONS INC's (NYSE:EBS) shares rose 57.51% to $3.04 during Thursday's pre-market session. Yesterday the company had a press release: Emergent BioSolutions Reports First Quarter 2024 Financial Results. |
| CVNA | 36.41% | Exciting news for CARVANA CO (NYSE:CVNA) as their shares soared 36.41% to $118.8 during the pre-market session on Thursday. A press release (Carvana Announces Record First Quarter 2024 Results) was released yesterday. |
| ASPN | 30.88% | Investors witnessed a remarkable surge in ASPEN AEROGELS INC (NYSE:ASPN) during Thursday's pre-market session, with the stock price rising 30.88% to $19.92. Shareholders saw the stock price going 33.86% higher in the past 3 months. |
| APVO | 28.13% | APTEVO THERAPEUTICS INC (NASDAQ:APVO) recorded a 28.13% increase in share price during the pre-market session, reaching $1.23 on Thursday. Building on yesterday's 35.08% gain, NASDAQ:APVO shows continued strength in today's pre-market session. |
| ENVX | 27.96% | During Thursday's pre-market session, ENOVIX CORP (NASDAQ:ENVX) exhibited strong growth, with the stock price climbing 27.96% to $8.33. A press release (Enovix Reaches Development Agreement with a Leading Smartphone OEM) was released yesterday. |
| LUNG | 23.06% | Investors witnessed a remarkable surge in PULMONX CORP (NASDAQ:LUNG) during Thursday's pre-market session, with the stock price rising 23.06% to $9.5. Yesterday the company had a press release: Pulmonx Reports First Quarter 2024 Financial Results. |
| EOLS | 20.52% | Exciting news for EVOLUS INC (NASDAQ:EOLS) as their shares soared 20.52% to $15.21 during the pre-market session on Thursday. In the last 6 months the stock gained 59.14%. |
| HYZN | 18.58% | HYZON MOTORS INC (NASDAQ:HYZN) rose 18.58% to $0.65 during Thursday's pre-market session. Today NASDAQ:HYZN is releasing earnings. In the last month the share price dropped with 31.14%. |
| ARBE | 17.32% | ARBE ROBOTICS LTD (NASDAQ:ARBE) rose 17.32% to $2.1 during Thursday's pre-market session. A press release (Arbe to Participate at the Oppenheimer 9th Annual Emerging Growth Conference) was released earlier today. |
To see the full list of premarket gainers you can use our premarket gainers page.
Pre-market losers
| Ticker | Change | Comment |
|---|---|---|
| FSLY | -35.58% | During Thursday's pre-market session, the shares of FASTLY INC - CLASS A (NYSE:FSLY) declined by 35.58%, reaching $8.33. A press release (Fastly Announces First Quarter 2024 Financial Results) was released yesterday. |
| FRSH | -27.73% | FRESHWORKS INC-CL A's (NASDAQ:FRSH) stock price is declining with 27.73% to a price of $13.19. A press release (Freshworks Announces CEO Transition) was released yesterday. |
| SAVAW | -20.38% | The pre-market session on Thursday witnessed a 20.38% decrease in CASSAVA SCIENCES INC-28's (NASDAQ:SAVAW) shares, with the stock price falling to $0.1. The negative sentiment prevails for NASDAQ:SAVAW as it recorded a -46.19% decline during the regular session yesterday, followed by another decline of 20.38% in today's pre-market session. |
| VSTS | -20.19% | The stock price of VESTIS CORP (NYSE:VSTS) is experiencing a decline of 20.19%, reaching $14.74 in today's pre-market session on Thursday. yesterday the company released their earnings. Earlier today the company had a press release: Vestis Reports Second Quarter 2024 Results and Updates Full-Year Outlook. |
| RELY | -15.62% | REMITLY GLOBAL INC's (NASDAQ:RELY) stock price decreased by 15.62% to $14.8. Yesterday the company had a press release: Remitly Reports First Quarter 2024 Results. |
| IMCC | -14.68% | The pre-market session on Thursday witnessed a 14.68% decrease in IM CANNABIS CORP's (NASDAQ:IMCC) shares, with the stock price falling to $0.95. Yesterday's significant 29.07% gain in NASDAQ:IMCC is met with a 14.68% decline in today's pre-market session, reflecting a shift in market sentiment. |
| MRAM | -14.55% | EVERSPIN TECHNOLOGIES INC's (NASDAQ:MRAM) shares experienced a 14.55% decline, falling to $6.4 during Thursday's pre-market session. |
| HRTG | -14.48% | Investors observed a 14.48% decline in HERITAGE INSURANCE HOLDINGS's (NYSE:HRTG) stock price, which now stands at $8.8 during Thursday's pre-market session. In the last 3 months the share price increased with 75.3%. |
| CSSEP | -14.29% | CHICKEN SOUP FOR SOUL - CSSE 9 3/4 PERP's (NASDAQ:CSSEP) shares fell 14.29% to $2.1 during Thursday's pre-market session. Yesterday's 92.91% gain in NASDAQ:CSSEP gives way to a 14.29% decrease in today's pre-market session, showcasing market fluctuations. |
| ETSY | -13.79% | During Thursday's pre-market session, the shares of ETSY INC (NASDAQ:ETSY) declined by 13.79%, reaching $60.12. In the last year the share price dropped with 22.51%. |
For the full premarket loser list go to our premarket losers page.
ALLARITY THERAPEUTICS INC
NASDAQ:ALLR (5/17/2024, 7:00:01 PM)
After market: 0.6355 0 (-0.55%)0.639
-0.03 (-5.02%)
ALLR News
3 days ago - InvestorPlaceALLR Stock Earnings: Allarity Therapeutics Reported Results for Q1 2024Allarity Therapeutics just reported results for the first quarter of 2024.
3 days ago - BusinessInsiderALLR Stock Earnings: Allarity Therapeutics Reported Results for Q1 2024InvestorPlace - Stock Market News, Stock Advice & Trading Tips Allarity Therapeutics (NASDAQ:ALLR) just reported results for the first quarter...
4 days ago - Allarity Therapeutics, Inc.Allarity Therapeutics Reports First Quarter Financial Results and Highlights, including Clear Clinical Benefits from Phase 2 Trial, NASDAQ Compliance, and Significant Improvement in Cash and Equity Balances- Phase 2 Trial of Stenoparib Concluded Early due to Clear Clinical Benefits Achieved - On Track to Regain Compliance with All Nasdaq Listing Requirements...
11 days ago - ChartmillUnusual volume stocks in Tuesday's sessionJoin us as we delve into today's session and uncover the stocks that are standing out with unusual volume.
11 days ago - ChartmillTop movers in Tuesday's sessionThese stocks are moving in today's session
11 days ago - Allarity Therapeutics, Inc.Allarity Therapeutics Announces that All Series A Preferred and All Variable Priced Warrants have Converted to Common Stock- Conversions Eliminate All Variable Priced Derivative Securities - Conversions Eliminate Any Market Overhang from Warrants - Series A Preferred and...
12 days ago - Allarity Therapeutics, Inc.Allarity Therapeutics Exceeds Nasdaq’s Minimum Equity Requirement; Requests Voluntarily Withdrawal of Form S-1- Stockholders’ equity significantly surpasses the $2.5 million minimum required by Nasdaq - Company is to seek Nasdaq’s formal confirmation of...
15 days ago - ChartmillWhich stocks are experiencing notable movement on Friday?Which stocks are experiencing notable movement on Friday?
16 days ago - ChartmillThursday's session is buzzing with activity. Check out the stocks that are attracting the most attention and driving market activity!Let's dive into the action on the US markets on Thursday. Here are the most active stocks that are driving the market today.
